Congratulations to Sanket and Maria for their recent review on “Immunogenic cell death induction by anticancer chemotherapeutics”. The review is part of the Trial watch articles which highlight the latest research in clinical trials. In the review they discuss recent progress on the development of ICD-inducing chemotherapeutic regimens, focusing on studies that evaluate clinical efficacy in conjunction with immunological biomarkers.

see http://www.tandfonline.com/doi/figure/10.1080/2162402X.2017.1386829?scroll=top&needAccess=true